Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Launay

Showing results (121-130 of 307) with videos related to

Pageof 31
Sort By:
Presse Medicale (Paris, France : 1983)|January 14, 2010
[Neuropsychiatric manifestations in systemic sclerosis]David Launay, Thierry Baubet, Olivier Cottencin, et al.
Clinical Immunology (Orlando, Fla.)|October 15, 2025
Dual role of plasmablasts as immune regulators or amplifiers in COVID-19Emmanuel Ledoult, Thomas Guerrier, Sylvain Dubucquoi, et al.
Frontiers in Immunology|July 19, 2019
Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature ReviewAmélie Leurs, Viviane Gnemmi, Arnaud Lionet, et al.
Environmental Pollution (Barking, Essex : 1987)|February 11, 2026
Ingestion of a human-relevant mixture of environmentally sourced microplastics promotes inflammation and tumorigenesis in the mouse colonMadjid Djouina, Muriel Pichavant, Christophe Waxin, et al.
BMC Nephrology|November 11, 2018
Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre studyDimitri Titeca-Beauport, Alexis Francois, Thierry Lobbedez, et al.
Clinical Rheumatology|February 4, 2014
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximabMarion Heusele, Pierre Clerson, Benoit Guery, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2019
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic SclerosisVincent Sobanski, Jonathan Giovannelli, Yannick Allanore, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2010
Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosusDavid Launay, Jean Schmidt, Sébastien Lepers, et al.
Journal of Clinical Immunology|August 26, 2022
Correction to: Protein‑losing Enteropathy as a Complication and/or Differential Diagnosis of Common Variable ImmunodeficiencySébastien Sanges, Nicolas Germain, Stéphane Vignes, et al.
Proteomics|October 19, 2021
Passages in culture and stimulation conditions influence protein expression of primary fibroblastsSolange Vivier, Aurélien Chepy, Fabrice Bray, et al.
Pageof 31

Showing results (121-130 of 307) with videos related to

Sort By:
Pageof 31
Presse Medicale (Paris, France : 1983)|January 14, 2010
[Neuropsychiatric manifestations in systemic sclerosis]David Launay, Thierry Baubet, Olivier Cottencin, et al.
Clinical Immunology (Orlando, Fla.)|October 15, 2025
Dual role of plasmablasts as immune regulators or amplifiers in COVID-19Emmanuel Ledoult, Thomas Guerrier, Sylvain Dubucquoi, et al.
Frontiers in Immunology|July 19, 2019
Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature ReviewAmélie Leurs, Viviane Gnemmi, Arnaud Lionet, et al.
Environmental Pollution (Barking, Essex : 1987)|February 11, 2026
Ingestion of a human-relevant mixture of environmentally sourced microplastics promotes inflammation and tumorigenesis in the mouse colonMadjid Djouina, Muriel Pichavant, Christophe Waxin, et al.
BMC Nephrology|November 11, 2018
Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre studyDimitri Titeca-Beauport, Alexis Francois, Thierry Lobbedez, et al.
Clinical Rheumatology|February 4, 2014
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximabMarion Heusele, Pierre Clerson, Benoit Guery, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2019
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic SclerosisVincent Sobanski, Jonathan Giovannelli, Yannick Allanore, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2010
Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosusDavid Launay, Jean Schmidt, Sébastien Lepers, et al.
Journal of Clinical Immunology|August 26, 2022
Correction to: Protein‑losing Enteropathy as a Complication and/or Differential Diagnosis of Common Variable ImmunodeficiencySébastien Sanges, Nicolas Germain, Stéphane Vignes, et al.
Proteomics|October 19, 2021
Passages in culture and stimulation conditions influence protein expression of primary fibroblastsSolange Vivier, Aurélien Chepy, Fabrice Bray, et al.
Pageof 31